Connors Investor Services’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,345
| Closed | -$207K | – | 161 |
|
|
2023
Q2 | $207K | Sell |
4,345
-3,285
| -43% | -$148K | 0.02% | 146 |
|
|
2023
Q1 | $300K | Sell |
7,630
-570
| -7% | -$20.7K | 0.04% | 122 |
|
|
2022
Q4 | $232K | Hold |
8,200
| – | – | 0.03% | 134 |
|
|
2022
Q3 | $246K | Hold |
8,200
| – | – | 0.03% | 124 |
|
|
2022
Q2 | $278K | Hold |
8,200
| – | – | 0.04% | 120 |
|
|
2022
Q1 | $368K | Sell |
8,200
-500
| -6% | -$23.1K | 0.04% | 117 |
|
|
2021
Q4 | $402K | Sell |
8,700
-1,300
| -13% | -$52.4K | 0.04% | 117 |
|
|
2021
Q3 | $336K | Sell |
10,000
-409
| -4% | -$13.9K | 0.04% | 124 |
|
|
2021
Q2 | $306K | Hold |
10,409
| – | – | 0.03% | 126 |
|
|
2021
Q1 | $268K | Hold |
10,409
| – | – | 0.03% | 133 |
|
|
2020
Q4 | $237K | Hold |
10,409
| – | – | 0.03% | 127 |
|
|
2020
Q3 | $223K | Hold |
10,409
| – | – | 0.03% | 119 |
|
|
2020
Q2 | $242K | Hold |
10,409
| – | – | 0.04% | 117 |
|
|
2020
Q1 | $222K | Sell |
10,409
-2,362
| -18% | -$56.2K | 0.04% | 110 |
|
|
2019
Q4 | $299K | Hold |
12,771
| – | – | 0.04% | 113 |
|
|
2019
Q3 | $268K | Hold |
12,771
| – | – | 0.04% | 118 |
|
|
2019
Q2 | $261K | Hold |
12,771
| – | – | 0.03% | 120 |
|
|
2019
Q1 | $359K | Hold |
12,771
| – | – | 0.05% | 105 |
|
|
2018
Q4 | $312K | Sell |
12,771
-2,916
| -19% | -$78.4K | 0.05% | 106 |
|
|
2018
Q3 | $583K | Sell |
15,687
-10,813
| -41% | -$292K | 0.08% | 97 |
|
|
2018
Q2 | $550K | Sell |
26,500
-6,500
| -20% | -$115K | 0.08% | 99 |
|
|
2018
Q1 | $475K | Hold |
33,000
| – | – | 0.07% | 100 |
|
|
2017
Q4 | $500K | Hold |
33,000
| – | – | 0.07% | 100 |
|
|
2017
Q3 | $317K | Hold |
33,000
| – | – | 0.05% | 113 |
|
|
2017
Q2 | $284K | Buy |
33,000
+3,000
| +10% | +$25.6K | 0.04% | 121 |
|
|
2017
Q1 | $267K | Buy |
30,000
+10,000
| +50% | +$92.7K | 0.04% | 124 |
|
|
2016
Q4 | $222K | Buy |
20,000
+6,000
| +43% | +$64.6K | 0.04% | 134 |
|
|
2016
Q3 | $238K | Buy |
14,000
+2,000
| +17% | +$37K | 0.04% | 128 |
|
|
2016
Q2 | $261K | Hold |
12,000
| – | – | 0.05% | 123 |
|
|
2016
Q1 | $230K | Buy |
12,000
+2,000
| +20% | +$38.3K | 0.05% | 131 |
|
|
2015
Q4 | $280K | Sell |
10,000
-9,000
| -47% | -$254K | 0.06% | 113 |
|
|
2015
Q3 | $463K | Hold |
19,000
| – | – | 0.1% | 98 |
|
|
2015
Q2 | $442K | Hold |
19,000
| – | – | 0.09% | 101 |
|
|
2015
Q1 | $289K | Hold |
19,000
| – | – | 0.06% | 115 |
|
|
2014
Q4 | $245K | Buy |
19,000
+2,000
| +12% | +$17.3K | 0.06% | 122 |
|
|
2014
Q3 | $119K | Buy |
+17,000
| New | +$154K | 0.03% | 150 |
|
Other funds holding IRMD
NTCM
SCM
RCMC
BCM
RIM
Connors Investor Services's IRMD Position: Q3 2023 in Review
Connors Investor Services sold out of iRadimed (IRMD) in Q3 2023, closing a stake of 4,345 shares — an estimated $207K sold.
Connors Investor Services first reported a position in IRMD in Q3 2014 and held it in 36 quarters. The position peaked at $583K in Q3 2018. 113 funds tracked by Wall St. Rank hold IRMD as of Q3 2023.
- Connors Investor Services reported no remaining iRadimed position as of Q3 2023 after selling out during the quarter.
- Connors Investor Services sold 4,345 iRadimed shares in Q3 2023, an estimated $207K.
- Connors Investor Services first reported a position in iRadimed in Q3 2014 and held it in 36 quarters.
- Connors Investor Services's iRadimed position peaked at $583K in Q3 2018.
- 113 funds tracked by Wall St. Rank held iRadimed as of Q3 2023.
Based on Connors Investor Services's 13F filing for Q3 2023, filed 22 Nov 2023.